Department of Pediatrics, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China.
Beijing Hong Jian Medical Device Company, Beijing, 100176, China.
Orphanet J Rare Dis. 2022 Mar 4;17(1):112. doi: 10.1186/s13023-022-02211-1.
Mucopolysaccharidoses are a group of lysosomal storage disorders caused by deficiency of enzymes involved in glycosaminoglycans degradation. Relationship between mucopolysaccharidoses and related enzymes has been clarified clearly. Based on such relationship, lots of therapies have been commercialized or are in the process of research and development. However, many potential treatments failed, because those treatments did not demonstrate expected efficacy or safety data. Molecular environment of enzyme, which is essential for their expression and activity, is fundamental for efficacy of therapy. In addition to enzyme activities, mucopolysaccharidoses-related enzymes have other atypical functions, such as regulation, which may cause side effects. This review tried to discuss molecular environment and atypical function of enzymes that are associated with mucopolysaccharidoses, which is very important for the efficacy and safety of potential therapies.
黏多糖贮积症是一组溶酶体贮积病,由参与糖胺聚糖降解的酶缺乏引起。黏多糖贮积症与相关酶之间的关系已经得到明确阐明。基于这种关系,许多疗法已经商业化或正在研究和开发中。然而,许多潜在的治疗方法都失败了,因为这些治疗方法没有显示出预期的疗效或安全性数据。酶的分子环境对其表达和活性至关重要,是治疗效果的基础。除了酶活性外,黏多糖贮积症相关酶还具有其他非典型功能,如调节功能,这可能会导致副作用。本文试图讨论与黏多糖贮积症相关的酶的分子环境和非典型功能,这对潜在治疗方法的疗效和安全性非常重要。